FDA Fast-Tracks Psychedelic Treatments for Mental Illness

The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive.

Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.